Skip to content
The Home Health AI Atlas
Answers

Medicare rules for home infusion therapy

◇

Medicare's home infusion drug is a parenteral drug or biological given intravenously, or subcutaneously over 15 minutes or more, at home, through a pump that is durable medical equipment1. Medicare pays 80 percent of the lesser of the actual charge or the fee schedule amount2.

42 CFR 486.505 Definitions, paragraph 'Home infusion drug' 42 CFR 414.1550

Insulin pumps and self-administered drugs sit outside

Insulin pump systems and self-administered drugs on a self-administered drug exclusion list are excluded from Medicare's definition1.

42 CFR 486.505 Definitions, paragraph 'Home infusion drug'

A discharge alone does not bring the higher payment back

A returning patient earns the higher first-visit payment again only when the earlier home infusion claim showed a discharge and more than 60 days have passed since the last home infusion therapy claim3. Bill the earlier discharge correctly: if the prior claim never showed one, the returning patient is treated as continuing and the higher first-visit payment is not allowed again3. Payment is one payment per payment category for each infusion drug administration calendar day, so the category the drug falls into decides what each day of therapy pays2.

42 CFR 414.1550

Sources

  1. Office of the Federal Register / eCFR, 42 CFR 486.505 Definitions, paragraph 'Home infusion drug', checked 2026-10-12
  2. Office of the Federal Register, eCFR, 42 CFR 414.1550(a)-(c), checked 2026-10-12
  3. Office of the Federal Register (eCFR), 42 CFR 414.1550(c)(4)(ii), paragraphs (A) and (B), checked 2026-10-12